ExpandMedication for Opioid Use Disorder in First Trimester Associated with Improved Birth Outcomes
Babies born to mothers with opioid use disorder (OUD) who are prescribed buprenorphine and buprenorphine/naloxone combination medications in the first trimester of pregnancy have a reduced risk of premature birth, low birth weight, and NICU admission when compared to babies born to mothers who are not prescribed medication for OUD.

















